The costs of myocardial infarction-a longitudinal analysis using data from a large German health insurance company

被引:8
|
作者
Reinhold T. [1 ]
Lindig C. [1 ]
Willich S. [1 ]
Brüggenjürgen B. [1 ]
机构
[1] Institute for Social Medicine, Epidemiology and Health Economics, Charité-University Medical Center, Berlin 10117
关键词
Costs; Economic burden; Myocardial infarction; Retrospective data analysis;
D O I
10.1007/s10389-011-0420-8
中图分类号
学科分类号
摘要
Aim: Cardiovascular diseases are a major health problem in the industrialised world. The aim of the study was to measure the course of costs after a myocardial infarction. Subject and methods: We undertook a retrospective review of the medical, hospital and drug claims data in the database of a German statutory health insurance company covering about 5 million insured persons. The data of patients suffering from myocardial infarction were extracted by using the documented hospital ICD-10 codes during 2004 and 2005. For these patients we reviewed and summarised all the charges incurred over a 1-year period after the initial index event on the basis of weekly costs and from the third party payer's perspective. Results: We included 15,185 patients with a primary diagnosis of MI-DRG (57.43% male patients, mean age of 71.1 ± 12.6 years). The average weekly total first-year cost of a first myocardial infarction was calculated at about 251 ± 1,077 Euros per patient. The cumulative total cost was about 13,061 ± 1,162 Euros per patient for the first year. The largest burden of the first year after myocardial infarction is due to in-patient stays. This represents approximately 80% of the total costs (about 10,505 ± 1,107 Euros per year and patient). Conclusion: Myocardial infarction is associated with significant economic costs from the perspective of statutory health insurance. This cost burden particularly occurs within the first 2 weeks following a first myocardial infarction. For this reason, efficient management of the acute event is outstandingly important. © 2011 Springer-Verlag.
引用
收藏
页码:579 / 586
页数:7
相关论文
共 50 条
  • [1] The costs of atrial fibrillation in patients with cardiovascular comorbidities-a longitudinal analysis of German health insurance data
    Reinhold, Thomas
    Lindig, Claudia
    Willich, Stefan N.
    Brueggenjuergen, Bernd
    [J]. EUROPACE, 2011, 13 (09): : 1275 - 1280
  • [2] Impact of cardio-metabolic risk on health care costs before and after an acute myocardial infarction in an elderly population from a health insurance company
    Florez, H.
    Palacio, A.
    Parris, D.
    Yang, Y.
    Uribe, C.
    Ben-Joseph, R.
    Tamariz, L.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (04) : S206 - S206
  • [3] Antipsychotic Prescription in Children and Adolescents An Analysis of Data From a German Statutory Health Insurance Company From 2005 to 2012
    Bachmann, Christian J.
    Lempp, Thomas
    Glaeske, Gerd
    Hoffmann, Falk
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (03): : 25 - +
  • [4] Gender differences in acute myocardial infarction-A nationwide German real-life analysis from 2014 to 2017
    Kuehnemund, Leonie
    Koeppe, Jeanette
    Feld, Jannik
    Wiederhold, Achim
    Illner, Julia
    Makowski, Lena
    Gerss, Joachim
    Reinecke, Holger
    Freisinger, Eva
    [J]. CLINICAL CARDIOLOGY, 2021, 44 (07) : 890 - 898
  • [5] Antipsychotic Prescription in Children and Adolescents: An Analysis of Data From a German Statutory Health Insurance Company From 2005 to 2012
    Neraal, Terje
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2014, 111 (20): : 364 - 364
  • [6] RESOURCE UTILIZATION AND COSTS RELATED TO INFLAMMATORY BOWEL DISEASE: A LONGITUDINAL ANALYSIS BASED ON ROUTINE DATA FROM TWO GERMAN STATUTORY HEALTH INSURANCE PROVIDERS
    Maehs, M.
    Kofler, J.
    Heidenblut, U. L. H.
    Wendel, P.
    Droechel, D.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S175 - S175
  • [7] Validation of Algorithms to Identify Acute Myocardial Infarction, Stroke, and Cardiovascular Death in German Health Insurance Data
    Platzbecker, Katharina
    Voss, Annemarie
    Reinold, Jonas
    Elbrecht, Anne
    Biewener, Wolfgang
    Prieto-Alhambra, Daniel
    Joedicke, Annika M.
    Schink, Tania
    [J]. CLINICAL EPIDEMIOLOGY, 2022, 14 : 1351 - 1361
  • [8] COSTS OF SCHIZOPHRENIA WITHIN A LARGE GERMAN STATUTORY HEALTH INSURANCE FUND
    Zeidler, J.
    Mittendorf, T.
    Greiner, W.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A356 - A357
  • [9] Disease burden and direct medical costs of incident adult ADHD: A retrospective longitudinal analysis based on German statutory health insurance claims data
    Libutzki, Berit
    May, Melanie
    Gleitz, Markus
    Karus, Michael
    Neukirch, Benno
    Hartman, Catharina A.
    Reif, Andreas
    [J]. EUROPEAN PSYCHIATRY, 2020, 63 (01) : e86
  • [10] EPIDEMIOLOGY AND TREATMENT PATTERNS IN ADULT PATIENTS WITH ATOPIC DERMATITIS: ANALYSIS OF LONGITUDINAL DATA FROM THE GERMAN STATUTORY HEALTH INSURANCE SYSTEM
    Zietze, H. A.
    Augustin, M.
    Kienitz, C.
    Theobald, K.
    Ihle, P.
    Cabral, C.
    [J]. VALUE IN HEALTH, 2018, 21 : S431 - S431